Clinical Trial Update: Docetaxel in Locally Advanced Gastric Adenocarcinoma [Phase 2]

View source ↗

Summary

The Phase 2 trial of docetaxel in locally advanced gastric adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sanofi | Conditions: Stomach Neoplasms | Phase 2 | Status: COMPLETED